AMV Stock Overview
American Vietnamese Biotech Incorporation engages in the manufacturing and trading of medical diagnostic biological products in Vietnam.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
American Vietnamese Biotech Incorporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫3,200.00 |
| 52 Week High | ₫5,700.00 |
| 52 Week Low | ₫3,000.00 |
| Beta | 1.34 |
| 1 Month Change | -15.79% |
| 3 Month Change | -17.95% |
| 1 Year Change | -28.89% |
| 3 Year Change | -69.52% |
| 5 Year Change | -79.90% |
| Change since IPO | -63.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| AMV | VN Medical Equipment | VN Market | |
|---|---|---|---|
| 7D | 0% | 3.0% | 0.3% |
| 1Y | -28.9% | -6.9% | 14.3% |
Return vs Industry: AMV underperformed the VN Medical Equipment industry which returned -6.9% over the past year.
Return vs Market: AMV underperformed the VN Market which returned 14.3% over the past year.
Price Volatility
| AMV volatility | |
|---|---|
| AMV Average Weekly Movement | 5.8% |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in VN Market | 7.0% |
| 10% least volatile stocks in VN Market | 2.4% |
Stable Share Price: AMV's share price has been volatile over the past 3 months.
Volatility Over Time: AMV's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | n/a | n/a | www.amvibiotech.com |
American Vietnamese Biotech Incorporation engages in the manufacturing and trading of medical diagnostic biological products in Vietnam. The company develops centralized testing centers; and provides medical machinery and equipment, and testing chemicals. It also offers sterilizers, drug labeling machines, medical image disc recorders, medical dry films, medical dry film printers, and digital radiology systems; lizer infrared therapy machines; infusion pumps and electric injection pumps; automatic molecular biology testing machines and automatic immunoassay machines and chemicals; medical equipment, x-ray systems, mobile x-ray systems, portable c-arm x-ray systems, 3T and 1.5 T systems, portable color ultrasound systems, and CT scan systems; endoscopic wire washing machines; and medical software products.
American Vietnamese Biotech Incorporation Fundamentals Summary
| AMV fundamental statistics | |
|---|---|
| Market cap | ₫419.54b |
| Earnings (TTM) | ₫13.58b |
| Revenue (TTM) | ₫196.11b |
30.9x
P/E Ratio2.1x
P/S RatioIs AMV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AMV income statement (TTM) | |
|---|---|
| Revenue | ₫196.11b |
| Cost of Revenue | ₫146.84b |
| Gross Profit | ₫49.26b |
| Other Expenses | ₫35.68b |
| Earnings | ₫13.58b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 103.59 |
| Gross Margin | 25.12% |
| Net Profit Margin | 6.93% |
| Debt/Equity Ratio | 9.9% |
How did AMV perform over the long term?
See historical performance and comparison